Chronicles of the gig economy, autonomous vehicles, and the platforms reshaping transportation and delivery. Covering Uber, Lyft, DoorDash, Tesla, Waymo, and the race to autonomous mobility.
Stock market analysis, trading, and investment insights.
Amazon on Wednesday agreed to take a stake in Grubhub as part of a deal that will also give members of its Prime subscription program a one-year membership to the food delivery service.The partnership gives Amazon the option to take a 2% stake in Grubhub, the U.S
I'm still a little confused how this would manifest but I'm glad SEC is mandating companies think about climate change as a risk to their businesses
Bird sold a vision of micro-mobility and got me excited
Peloton shares tumbled more than 25% on Thursday, after the company reported weakening sales growth and a wider-than-expected loss in its fiscal first quarter.The company slashed its outlook for the full fiscal year amid softened demand for its exercise equipment and ongoing supply chain challenges
The Verge reports that, Lime, the electric scooter company, has raised over $500 million in funding and confirmed plans to go public
Advanced Micro Devices reported its revenues and earnings for the third quarter ended September 30 exceeded expectations, with revenue growing 54% to a record $4.3 billion.Non-GAAP net income for the quarter was $893 million, or 73 cents a share, beating expectations of 67 cents a share on a non-GAAP basis
Surprise surprise, Facebook beats profit estimates
San Jose, California-based PayPal has recently approached Pinterest about a potential deal, the people said, asking not to be identified because the talks are private
After Facebook acquired the popular GIF repository Giphy (reportedly for $400 million), the UK's Competition and Markets Authority (CMA) launched an investigation to determine if the merger would lessen competition
The World Health Organization has hired the company, called Afrigen Biologics and Vaccines, as part of a $100 million plan to figure out how to make an mRNA vaccine against COVID that is as close as possible to the version produced by Moderna.As to why WHO has chosen to try to copy Moderna rather than the other mRNA COVID vaccine, which is made by Pfizer BioNTech, Friede says the choice was practical."Moderna has reiterated on several occasions that they will not enforce their intellectual property during the pandemic," says Friede